The Fibrates Story — A Tepid End to a PROMINENT Drug | NEJM - nejm.org

[news]

The Fibrates Story — A Tepid End to a PROMINENT Drug | NEJM (https://news.google.com/__i/rss/rd/articles/CBMiMWh0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9wZGYvMTAuMT A1Ni9ORUpNZTIyMTMyMDjSAQA?oc=5) nejm.org
Pemafibrate Lowers Triglyceride Levels Among Adults with Type 2 Diabetes, Does Not Decrease Risk of Cardiovascular Events, Death (https://news.google.com/__i/rss/rd/articles/CBMioQFodHRwczovL3d3dy5waGFybWFjeXRpbWVzLmNvbS92aW V3L3BlbWFmaWJyYXRlLWxvd2Vycy10cmlnbHljZXJpZGUtbGV2 ZWxzLWFtb25nLWFkdWx0cy13aXRoLXR5cGUtMi1kaWFiZXRlcy 1kb2VzLW5vdC1kZWNyZWFzZS1yaXNrLW9mLWNhcmRpb3Zhc2N1 bGFyLWV2ZW50cy1kZWF0aNIBAA?oc=5) Pharmacy Times
Mixed Results With Pemafibrate in Patients With Type 2 Diabetes (https://news.google.com/__i/rss/rd/articles/CBMiN2h0dHBzOi8vd3d3Lm1lZHBhZ2V0b2RheS5jb20vbWVldG luZ2NvdmVyYWdlL2FoYS8xMDE1OTXSAQA?oc=5) Medpage Today
Novel drug lowers triglycerides, does not reduce cardiovascular events (https://news.google.com/__i/rss/rd/articles/CBMidWh0dHBzOi8vd3d3Lm5ld3MtbWVkaWNhbC5uZXQvbmV3cy 8yMDIyMTEwNi9Ob3ZlbC1kcnVnLWxvd2Vycy10cmlnbHljZXJp ZGVzLWRvZXMtbm90LXJlZHVjZS1jYXJkaW92YXNjdWxhci1ldm VudHMuYXNweNIBAA?oc=5) News-Medical.Net
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk | NEJM (https://news.google.com/__i/rss/rd/articles/CBMiM2h0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9mdWxsLzEwLj EwNTYvTkVKTW9hMjIxMDY0NdIBAA?oc=5) nejm.org
View Full Coverage on Google News (https://news.google.com/stories/CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2ozLX BTUEJoSEI3b3JqbTNaRG5TZ0FQAQ?oc=5)

More... (https://news.google.com/__i/rss/rd/articles/CBMiMWh0dHBzOi8vd3d3Lm5lam0ub3JnL2RvaS9wZGYvMTAuMT A1Ni9ORUpNZTIyMTMyMDjSAQA?oc=5)